Completed NA INTERVENTIONAL 4-arm NCT04270955

Dartmouth Middle Meningeal Embolization Trial (DaMMET) (DAMMET)

A Single Center Randomized Control Trial to Evaluate the Efficacy of Middle Meningeal Artery Embolization in the Treatment of Chronic Subdural Hematomas

Sponsor: Dartmouth-Hitchcock Medical Center

Conditions Chronic Subdural Hematoma Subdural Hematoma

Interventions Embolization of the Middle Meningeal Artery Standard of care including possible surgical evacuation of subdural hematoma

Updated 10 times since 2020 Last updated: Feb 20, 2024 Started: Mar 11, 2020 Primary completion: Jan 11, 2024 Completion: Jan 11, 2024

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT04270955, this NA trial focuses on Chronic Subdural Hematoma and Subdural Hematoma and remains completed. Sponsored by Dartmouth-Hitchcock Medical Center, it has been updated 10 times since 2020, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

10 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Mar 2024 — Jul 2024 [monthly]

Completed NA

Status: Recruiting → Completed
Mar 2023 — Mar 2024 [monthly]

Recruiting NA
Dec 2022 — Mar 2023 [monthly]

Recruiting NA

▶ Show 5 earlier versions

Jul 2022 — Dec 2022 [monthly]

Recruiting NA
Apr 2021 — Jul 2022 [monthly]

Recruiting NA
Jan 2021 — Apr 2021 [monthly]

Recruiting NA
Apr 2020 — Jan 2021 [monthly]

Recruiting NA
Mar 2020 — Apr 2020 [monthly]

Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Dartmouth-Hitchcock Medical Center

Data source: Dartmouth-Hitchcock Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Lebanon, United States